scholarly article | Q13442814 |
P2093 | author name string | Hui Wang | |
Dan Xu | |||
Yu Guo | |||
Liao-Bin Chen | |||
Jie Ping | |||
Ben-Jian Zhang | |||
P2860 | cites work | Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats | Q33246062 |
Acetaldehyde-mediated collagen regulation in hepatic stellate cells | Q33661177 | ||
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. | Q33888050 | ||
Pathogenesis of liver fibrosis: role of oxidative stress | Q34025940 | ||
Oxidative stress, plant-derived antioxidants and liver fibrosis | Q34623869 | ||
Liver fibrosis -- from bench to bedside | Q35068035 | ||
Hepatic fibrosis: molecular mechanisms and drug targets | Q35911848 | ||
Connective tissue biology and hepatic fibrosis: report of a conference | Q37905957 | ||
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts | Q38301076 | ||
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells | Q40225700 | ||
Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. | Q40334903 | ||
Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? | Q42285597 | ||
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. | Q42832329 | ||
The role of Smad3 in mediating mouse hepatic stellate cell activation | Q43657688 | ||
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers | Q43878352 | ||
Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver | Q44204335 | ||
The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo | Q44383140 | ||
Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidation | Q44969392 | ||
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. | Q46802333 | ||
Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells | Q47769851 | ||
Toxicity of hepatotoxins: new insights into mechanisms and therapy. | Q53668234 | ||
P433 | issue | 3 | |
P921 | main subject | hepatotoxicity | Q1349821 |
P304 | page(s) | 303-309 | |
P577 | publication date | 2007-10-30 | |
P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
P1476 | title | Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors | |
P478 | volume | 35 |
Q38966992 | 8-Hydroxy-2'-deoxyguanosine as a biomarker of oxidative DNA damage induced by perfluorinated compounds in TK6 cells. |
Q34494504 | A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats |
Q47723208 | Addition of Berberine to Preservation Solution in an Animal Model of Ex Vivo Liver Transplant Preserves Mitochondrial Function and Bioenergetics from the Damage Induced by Ischemia/Reperfusion |
Q26745650 | Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview |
Q36901429 | Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells |
Q57051612 | Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression |
Q55052225 | Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. |
Q38928488 | Berberis Vulgaris and Berberine: An Update Review |
Q33819605 | Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities |
Q33724172 | Berberis vulgaris extract/β-cyclodextrin complex increases protection of hepatic cells via suppression of apoptosis and lipogenesis pathways. |
Q38848565 | Bi-content micro-collagen chip provides contractility-based biomechanical readout for phenotypic drug screening with expanded and profiled targets |
Q64102549 | Chinese Herbal Medicine for Wilson's Disease: A Systematic Review and Meta-Analysis |
Q35575460 | Chinese medicines as a resource for liver fibrosis treatment |
Q26775055 | Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects |
Q87279784 | Effects of isoquinoline alkaloid berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats |
Q42519490 | Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease |
Q35131516 | Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells |
Q39342467 | Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1. |
Q42795444 | Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice |
Q38744898 | Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells |
Q52668163 | Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. |
Q51284373 | PASS-predicted hepatoprotective activity of Caesalpinia sappan in thioacetamide-induced liver fibrosis in rats. |
Q36175416 | Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control |
Q36357775 | Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats |
Q37210162 | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice |
Q38326327 | Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis |
Q42158636 | Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl₄-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression |
Q42176100 | Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice |
Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
Q42723826 | The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury |
Q36988577 | Update on berberine in nonalcoholic Fatty liver disease |
Search more.